Correction: Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons

Affiliations

• ¹ INMED, INSERM, Aix-Marseille University, Marseille, France.
• ² IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.
• ³ TAGC INSERM U1090, Aix-Marseille University, Marseille, France.
• ⁴ Phenotype Expertise, 5 Boulevard du Maréchal Koenig, Marseille, France.
• ⁵ Miltenyi Biotec, Bergisch-Gladbach, Germany.
• ⁶ Baylor College of Medicine, Houston, TX, USA.
• ⁷ Cook Children's Clinical Genetics, Fort Worth, TX, USA.
• ⁸ Division of genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ, USA.
• ⁹ Department of Medical Genetics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.
• ¹⁰ Pediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.
• ¹¹ Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.
• ¹² Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University and Ghent University Hospital, Ghent, Belgium.
• ¹³ Department of Neurology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
• ¹⁴ Université Libre de Bruxelles (ULB), Brussels, Belgium.
• ¹⁵ Neuropediatric Unit, Kannerklinik, Centre Hospitalier de Luxembourg, Luxembourg, Grand-Duchy of Luxembourg, Luxembourg, Luxembourg.
• ¹⁶ Centre Hospitalier Universitaire de Nantes, Service de Génétique Médicale, Nantes, France.
• ¹⁷ INSERM, CNRS, UNIV Nantes, l'institut du thorax, Nantes, France.
• ¹⁸ Hackensack University Medical Center, Hackensack, NJ, USA.
• ¹⁹ Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.
• ²⁰ Trousseau Hospital, Paris, France.
• ²¹ Max-Planck-Institute of Experimental Medicine, Goettingen, Germany.
• ²² INMED, INSERM, Aix-Marseille University, Marseille, France. antoine.de-chevigny@inserm.fr.